These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 28489583
1. Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis. Tang J, Qin Z, Li X, Han P, Wang F, Yang C, Li R, Wang K, Tang M, Wang W, Lv Q, Zhang W. Oncotarget; 2017 Jul 25; 8(30):50034-50050. PubMed ID: 28489583 [Abstract] [Full Text] [Related]
2. Vascular endothelial growth factor gene polymorphisms and the risk of renal cell carcinoma: Evidence from eight case-control studies. Gong M, Dong W, Shi Z, Qiu S, Yuan R. Oncotarget; 2017 Jan 31; 8(5):8447-8458. PubMed ID: 28039484 [Abstract] [Full Text] [Related]
3. Association between VEGF Gene Polymorphisms and the Susceptibility to Lung Cancer: An Updated Meta-Analysis. Yang F, Qin Z, Shao C, Liu W, Ma L, Shu Y, Shen H. Biomed Res Int; 2018 Jan 31; 2018():9271215. PubMed ID: 30013987 [Abstract] [Full Text] [Related]
4. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas. Kawai Y, Sakano S, Korenaga Y, Eguchi S, Naito K. Eur Urol; 2007 Oct 31; 52(4):1147-55. PubMed ID: 17287073 [Abstract] [Full Text] [Related]
5. Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis. Hou Q, Li MY, Huang WT, Wei FF, Peng JP, Lou MW, Qiu JG. Oncotarget; 2017 Jul 25; 8(30):50061-50070. PubMed ID: 28562357 [Abstract] [Full Text] [Related]
6. Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma. Yang SM, Huang CY, Shiue HS, Huang SP, Pu YS, Chen WJ, Lin YC, Hsueh YM. PLoS One; 2015 Jul 25; 10(12):e0145410. PubMed ID: 26701102 [Abstract] [Full Text] [Related]
7. Predictive role of vascular endothelial growth factor polymorphisms in the survival of renal cell carcinoma patients. Yang YQ, Chen J. Genet Mol Res; 2014 Jul 04; 13(3):5011-7. PubMed ID: 25062489 [Abstract] [Full Text] [Related]
8. Association between vascular endothelial growth factor rs699947 polymorphism and the risk of three major urologic neoplasms (bladder cancer, prostate cancer, and renal cell carcinoma): A meta-analysis involving 11,204 subjects. Song Y, Hu J, Chen Q, Guo J, Zou Y, Zhang W, Chen X, Hu W, Huang P. Gene; 2018 Dec 30; 679():241-252. PubMed ID: 30195633 [Abstract] [Full Text] [Related]
9. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas. Xian W, Zheng H, Wu WJ. Genet Mol Res; 2015 Jul 13; 14(3):7634-42. PubMed ID: 26214443 [Abstract] [Full Text] [Related]
10. Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients. Zhong W, Wang X, Pan B, Su Z. Tumour Biol; 2014 Oct 13; 35(10):9839-45. PubMed ID: 24989926 [Abstract] [Full Text] [Related]
11. Vascular endothelial growth factor +936C/T, -634G/C, -2578C/A, and -1154G/A polymorphisms with risk of preeclampsia: a meta-analysis. Cheng D, Hao Y, Zhou W, Ma Y. PLoS One; 2013 Oct 13; 8(11):e78173. PubMed ID: 24223772 [Abstract] [Full Text] [Related]
12. Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study. Shen BL, Qu QS, Miao SZ, Zhang YX. Genet Mol Res; 2015 Sep 22; 14(3):11119-25. PubMed ID: 26400342 [Abstract] [Full Text] [Related]
13. Vascular endothelial growth factor +405G/C and -2578C/A polymorphisms and breast cancer risk: a meta-analysis. Zhang Y, Yu YF, Wang JZ, Jia H. Genet Mol Res; 2015 Aug 03; 14(3):8909-18. PubMed ID: 26345822 [Abstract] [Full Text] [Related]
14. Vascular endothelial growth factor gene polymorphisms and gastric cancer risk: a meta-analysis. Zhuang M, Peng Z, Wang J, Su X. J BUON; 2017 Aug 03; 22(3):714-724. PubMed ID: 28730780 [Abstract] [Full Text] [Related]
15. Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals. Wang Z, Peng S, Xie H, Guo L, Cai Q, Shang Z, Jiang N, Niu Y. Clin Exp Med; 2018 May 03; 18(2):165-175. PubMed ID: 29362922 [Abstract] [Full Text] [Related]
16. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case-control study. Lu G, Dong Y, Zhang Q, Jiao L, Yang S, Shen B. Tumour Biol; 2015 Nov 03; 36(11):8645-52. PubMed ID: 26044558 [Abstract] [Full Text] [Related]
17. Analysis of the glutathione S-transferase genes polymorphisms in the risk and prognosis of renal cell carcinomas. Case-control and meta-analysis. Abid A, Ajaz S, Khan AR, Zehra F, Hasan AS, Sultan G, Mohsin R, Hashmi A, Niamatullah N, Rizvi SA, Mehdi SQ, Khaliq S. Urol Oncol; 2016 Sep 03; 34(9):419.e1-419.e12. PubMed ID: 27185341 [Abstract] [Full Text] [Related]
18. VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population. Sáenz-López P, Vazquez F, Cozar JM, Carretero R, Garrido F, Ruiz-Cabello F. Hum Immunol; 2013 Jan 03; 74(1):98-103. PubMed ID: 23073296 [Abstract] [Full Text] [Related]
19. Three Polymorphisms of Vascular Endothelial Growth Factor (+936C > T, -460C > T, and -2578C > A) and Their Susceptibility to Ovarian Cancer: A Meta-Analysis. Zhang X, Qin J, Qin A. Int J Gynecol Cancer; 2015 Jun 03; 25(5):779-85. PubMed ID: 25835351 [Abstract] [Full Text] [Related]
20. Vascular endothelial growth factor polymorphisms and risk of Alzheimer's disease: a meta-analysis. He D, Lu W, Chang K, Liu Y, Zhang J, Zeng Z. Gene; 2013 Apr 15; 518(2):296-302. PubMed ID: 23370341 [Abstract] [Full Text] [Related] Page: [Next] [New Search]